Press Release

Prothrombin Complex Concentrates Market Analysis, Insights, Global Industry Trend, Foresights till 2025: By Size, Growth, Trends and Share

The Global Prothrombin Complex Concentrate Market. CSL Limited held the highest market share due to emphasis on realigning its diversification strategy to improve the accessibility of its key PCC brands Kcentra and Beriplex.

The Global Prothrombin Complex Concentrates Market is probably going to pick up footing because of the huge drop sought after for its partner new solidified plasma (FFP). Fortune Business Insights has distributed a report, titled ‘Prothrombin Complex Concentrate Market Size, Share and Global Trend by Product Type (3-factor PCC, 4-factor PCC), Application (Congenital and Acquired Coagulation Factor insufficiency), End User (Hospitals, Ambulatory Surgical Centres) and Geography Forecast till 2025.

In this report, Fortune Business Insights has anticipated that this market, which was esteemed at US$536.3 MN in 2017, reach US$ 1,076.5 MN and in doing as such, it will show a CAGR of displaying a CAGR of 9.1%.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/prothrombin-complex-concentrate-market-100102

Clinical studies have proven that fresh frozen plasma needed much longer infusion time, as compared to prothrombin complex concentrate (PCC). Besides infusion time, PCC possess some other advantages over FFP. Some notable properties that have led to PCC’s increasing adoption are its ability to reconstitute in a short span. Furthermore, PCC is available easily due to its lack of blood group specificity. In addition to the aforementioned factors, a better safety profile of PCC has influenced users to prefer them over fresh frozen plasma.

Leading Companies Are Focusing On Setting Up Plasma Collection Centres

As companies are realizing the clinical advantages of PCC over fresh frozen plasma, they are now focusing on research and development of PCC. It is seen that there is an emphasis on stocking up plasma from blood that is required in PCC. To ensure that these needs are sufficed, leading companies such as Grifols SA and Octapharma are putting in increased efforts towards setting up plasma collection centres across several countries around the world.

Kcentra Has Changed the Face of PCC, Globally

Ever since Kcentra was approved by the FDA, it has been adopted by many healthcare professionals worldwide. Kcentra has proven efficient in restoring blood coagulation, as it is packed with certain factors that help replenish various clotting factors. Kcentra played a major role in treatments for patients who are undergoing warfarin therapy. Warfarin may lead to sever and acute blood loss and to minimize such losses and restoring coagulation factors, Kcentra has been proved beneficial. Therefore, the use of PCC in warfarin induced bleeding is leading to increased adoption which in turn has boosted the global market.

Browse Complete Report Details at  https://www.fortunebusinessinsights.com/industry-reports/prothrombin-complex-concentrate-market-100102

Increasing Government Initiatives and Funding to Boost the Global Market

Recent updates in policies regarding usage approval have boded well for prothrombin complex concentrates. There has been a relaxation in usage of PCC in treating bleeding disorders, globally. This has encouraged research analysts and related personnel to conduct more clinical trials and propose newer usage concepts to the regulatory authorities. Moreover, increasing government funding promoting the use of PCC in surgical procedures is boosting the global market. Proven clinical efficiency of PCC has encouraged governments across the world to promote the use of PCC for treating unwanted bleeding in surgical procedures. Furthermore, few alternatives are available to treat bleeding and the existing alternatives do not come close to the standards set by PCC. This in turn has led to an increase in demand for PCC and subsequently boosted the global PCC market.

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1. Prevalence of Coagulation Factor Deficiency – For Key Countries

4.2. Recent Industry Developments – Partnerships, Mergers & Acquisitions

4.3. Regulatory Scenario – For Key Countries

4.4. Analysis in Relation to Alternatives to PCC

4.5. Global PCC Market: Reimbursement Scenario & Key Industry Trends

View More Reports:s

Coronary Stents Market Worth US$ 8,414.5 Mn by Size, Share, Future Trends, Segmentation, Projection till 2025

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close